Carregant...
Effects of Exenatide on Weight and Appetite in Overweight Adolescents and Young Adults with Prader-Willi Syndrome
BACKGROUND: Prader-Willi Syndrome (PWS) is associated with hyperphagia and hyperghrelinemia with major morbidity due to obesity without effective medical treatment targeting hyperphagia. Exenatide [Byetta (synthetic Exendin-4); AstraZeneca, Wilmington DE] is a GLP-1 receptor agonist which reduces ap...
Guardat en:
| Publicat a: | Pediatr Obes |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5288290/ https://ncbi.nlm.nih.gov/pubmed/27071367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijpo.12131 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|